Versant Capital Management, Inc Mannkind Corp Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Mannkind Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 26 shares of MNKD stock, worth $92. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26
Previous 730
96.44%
Holding current value
$92
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$79.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$61.3 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$33.5 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$31 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$27.6 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $911M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...